دورية أكاديمية
أعرض في EDS

Skin and soft tissue infections in solid organ transplants.

التفاصيل البيبلوغرافية
العنوان: Skin and soft tissue infections in solid organ transplants.
المؤلفون: Peghin M; Infectious and Tropical Diseases Unit, Department of Medicine and Surgery, University of Insubria, ASST-Sette Laghi, Varese, Italy., Graziano E, Grossi PA
المصدر: Current opinion in infectious diseases [Curr Opin Infect Dis] 2024 Apr 01; Vol. 37 (2), pp. 112-120. Date of Electronic Publication: 2023 Dec 04.
نوع المنشور: Review; Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8809878 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-6527 (Electronic) Linking ISSN: 09517375 NLM ISO Abbreviation: Curr Opin Infect Dis Subsets: MEDLINE
أسماء مطبوعة: Publication: Hagerstown, Md. : Lippincott Williams & Wilkins
Original Publication: London, UK ; Philadelphia, PA : Gower Academic Journals, c1988-
مواضيع طبية MeSH: Soft Tissue Infections*/diagnosis , Soft Tissue Infections*/epidemiology , Soft Tissue Infections*/etiology , Organ Transplantation*/adverse effects , Transplants*, Humans ; Transplant Recipients
مستخلص: Purpose of Review: Skin and soft tissue infections (SSTI) in solid organ transplant (SOT) recipients may be a great challenge for clinicians caring for SOT due to the involvement of both common and opportunistic pathogens associated with a blunted immune response. The purpose of this review is to outline current literature and describe open issues on the management of SSTI in this special population.
Recent Findings: Clinical presentation in SOT recipients can manifest as isolated skin lesions after primary inoculation or be the sign of a disseminated infection. Tissue samples for microscopy and histopathology are crucial to making an accurate diagnosis given the nonspecific and heterogeneous appearance of skin lesions. Multidisciplinary teams are required for a comprehensive diagnosis and management.
Summary: SSTI are frequent contributors to morbidity and mortality in SOT. Specific research focused on the clinical presentation, risk factors and management in this special population is needed.
(Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
References: Roberts MB, Fishman JA. Immunosuppressive agents and infectious risk in transplantation: managing the “net state of immunosuppression”. Clin Infect Dis 2021; 73:e1302–e1317.
Mularoni A, Graziano E, Todaro F. Invasive Trichophyton infection in a liver transplant recipient. Transpl Infect Dis 2022; 24:e13794.
Sartelli M, Guirao X, Hardcastle TC, et al. 2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections. World J Emerg Surg 2018; 13:58.
Kentley J, Allawh R, Rao S, et al. The burden of cutaneous disease in solid organ transplant recipients of color. Am J Transplant 2021; 21:1215–1226.
Jaros J, Hunt S, Mose E, et al. Cutaneous metastases: a great imitator. Clin Dermatol 2020; 38:216–222.
Luu T, Khalid R, Rehman T, Clark NM. Disseminated Nocardia paucivorans infection resembling metastatic disease in a kidney transplant recipient. Cureus 2022; 14:e25365.
Cutler TS, Jannat-Khah DP, Kam B, et al. Prevalence of misdiagnosis of cellulitis: a systematic review and meta-analysis. J Hosp Med 2023; 18:254–261.
Nightingale R, Yadav K, Hamill L, et al. Misdiagnosis of uncomplicated cellulitis: a systematic review and meta-analysis. J Gen Intern Med 2023; 38:2396–2404.
Rolon AM, Tolaymat LM, Sokumbi O, Bodiford K. The role of excision for treatment of chromoblastomycosis: a cutaneous fungal infection frequently mistaken for squamous cell carcinoma. Dermatol Surg 2023; 49:649–653.
Naidoo S, Zwane AM, Paruk A, Hardcastle TC. Diagnosis and management of severe water-related skin and soft tissue sepsis: a summative review of the literature. Diagnostics (Basel) 2023; 13:2150.
Watkins RR, David MZ. Approach to the patient with a skin and soft tissue infection. Infect Dis Clin North Am 2021; 35:1–48.
Libson K, Johnson K, Plaza JA, et al. Skin biopsies are associated with a lower risk of rehospitalization among hospitalized patients with skin and soft tissue infections: a cross-sectional study. Int J Dermatol 2023; 62:e538–e540.
Hitchcock AM, Seabury RW, Kufel WD, et al. Does a positive methicillin-resistant Staphylococcus aureus (MRSA) nasal screen predict the risk for MRSA SKIN AND SOFT TISSUE INFECTION? Ann Pharmacother 2023; 57:669–676.
Imlay H, Laundy NC, Forrest GN, Slavin MA. Shorter antibiotic courses in the immunocompromised: the impossible dream? Clin Microbiol Infect 2023; 29:143–149.
Dryden M. Novel techniques in the treatment of skin and soft tissue infection. Curr Opin Infect Dis 2022; 35:72–78.
Peghin M, Graziano E, Rovelli C, Grossi PA. Prevention and treatment of recurrent cellulitis. Curr Opin Infect Dis 2023; 36:95–101.
Pereira MR, Rana MM, Practice AICo. Methicillin-resistant Staphylococcus aureus in solid organ transplantation—guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019; 33:e13611.
Esposito S, Blasi F, Curtis N, et al. New antibiotics for Staphylococcus aureus infection: an update from the World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Italian Society of Anti-Infective Therapy (SITA). Antibiotics (Basel) 2023; 12:742.
Graziano E, Peghin M, Grossi PA. Perioperative antibiotic stewardship in the organ transplant setting. Transpl Infect Dis 2022; 24:e13895.
Carey GB, Holleck JL, Ein Alshaeba S, et al. Estimated mortality with early empirical antibiotic coverage of methicillin-resistant Staphylococcus aureus in hospitalized patients with bacterial infections: a systematic review and meta-analysis. J Antimicrob Chemother 2023; 78:1150–1159.
Cobo-Vazquez E, Aguilera-Alonso D, Carrasco-Colom J, et al. Increasing incidence and severity of invasive Group A streptococcal disease in Spanish children in 2019–2022. Lancet Reg Health Eur 2023; 27:100597.
Gouveia C, Bajanca-Lavado MP, Mamede R, et al. Sustained increase of paediatric invasive Streptococcus pyogenes infections dominated by M1(UK) and diverse emm12 isolates, Portugal, September 2022 to May 2023. Euro Surveill 2023; 28:2300427.
Rodriguez-Ruiz JP, Lin Q, Lammens C, et al. Increase in bloodstream infections caused by emm1 group A Streptococcus correlates with emergence of toxigenic M1(UK), Belgium, May 2022 to August 2023. Euro Surveill 2023; 28:2300422.
Johannesen TB, Munkstrup C, Edslev SM, et al. Increase in invasive group A streptococcal infections and emergence of novel, rapidly expanding sub-lineage of the virulent Streptococcus pyogenes M1 clone, Denmark, 2023. Euro Surveill 2023; 28:2300291.
https://www.ecdc.europa.eu/en/news-events/increase-invasive-group-streptococcal-infections-among-children-europe-including .
Cortes-Penfield N, Ryder JH. Should linezolid replace clindamycin as the adjunctive antimicrobial of choice in group A Streptococcal necrotizing soft tissue infection and toxic shock syndrome? A focused debate. Clin Infect Dis 2023; 76:346–350.
Russo A, Trecarichi EM, Torti C. The role of Gram-negative bacteria in skin and soft tissue infections. Curr Opin Infect Dis 2022; 35:95–102.
Dietl B, Sanchez I, Arcenillas P, et al. Ceftolozane/tazobactam in the treatment of osteomyelitis and skin and soft-tissue infections due to extensively drug-resistant Pseudomonas aeruginosa : clinical and microbiological outcomes. Int J Antimicrob Agents 2018; 51:498–502.
Bassetti M, Castaldo N, Cattelan A, et al. Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience. Int J Antimicrob Agents 2019; 53:408–415.
Hamed A, Niehaus AG, Bosshardt Hughes O, Jakharia N. Ecthyma gangrenosum without bacteremia in a 54-year-old woman with heart transplant. Transpl Infect Dis 2020; 22:e13319.
De Benedetto I, Curtoni A, Lupia T, et al. Nodular cutaneous lesions in immune-compromised hosts as a clue for the diagnosis of disseminated nocardiosis: from bedside to microbiological identification. Pathogens 2022; 12:68.
Yetmar ZA, Chesdachai S, Duffy D, et al. Risk factors and prophylaxis for nocardiosis in solid organ transplant recipients: a nested case-control study. Clin Transplant 2023; 37:e15016.
Yetmar ZA, Challener DW, Seville MT, et al. Outcomes of nocardiosis and treatment of disseminated infection in solid organ transplant recipients. Transplantation 2023; 107:782–791.
Conan PL, Matignon M, Bleibtreu A, et al. Trimethoprim/sulfamethoxazole for nocardiosis in solid organ transplant recipients: real-life data from a multicentre retrospective study. Transpl Infect Dis 2021; 23:e13669.
Okaro U, Addisu A, Casanas B, et al. An emerging cause of blood-culture-negative endocarditis. Clin Microbiol Rev 2017; 30:709–746.
Mularoni A, Mikulska M, Barbera F, et al. Molecular analysis with 16S rRNA PCR/Sanger sequencing and molecular antibiogram performed on DNA extracted from valve improve diagnosis and targeted therapy of infective endocarditis: a prospective study. Clin Infect Dis 2023; 76:e1484–e1491.
Morillas JA, Hassanein M, Syed B, et al. Early posttransplant cutaneous bacillary angiomatosis in a kidney recipient: case report and review of the literature. Transpl Infect Dis 2021; 23:e13670.
Subramanian AK, Theodoropoulos NM. Infectious diseases community of practice of the American Society of T. Mycobacterium tuberculosis infections in solid organ transplantation: guidelines from the infectious diseases community of practice of the American Society of Transplantation. Clin Transplant 2019; 33:e13513.
Clemente WT, Faria LC, Cota GF, et al. Donor-derived tuberculosis: a case report and the role of communication gaps in transplantation safety. Case Rep Transplant 2021; 2021:8816426.
Franco-Paredes C, Marcos LA, Henao-Martinez AF, et al. Cutaneous mycobacterial infections. Clin Microbiol Rev 2018; 32:e00069.
Abad CL, Razonable RR. Nontuberculous mycobacterial infections in solid organ transplant recipients: an update. J Clin Tuberc Other Mycobact Dis 2016; 4:1–8.
Scriven JE, Scobie A, Verlander NQ, et al. Mycobacterium chimaera infection following cardiac surgery in the United Kingdom: clinical features and outcome of the first 30 cases. Clin Microbiol Infect 2018; 24:1164–1170.
Malinis M, Koff A. Mycobacterium tuberculosis in solid organ transplant donors and recipients. Curr Opin Organ Transplant 2021; 26:432–439.
Longworth SA, Daly JS. Practice ASTIDCo. Management of infections due to nontuberculous mycobacteria in solid organ transplant recipients-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019; 33:e13588.
Cariello PF, Kwak EJ, Abdel-Massih RC, Silveira FP. Safety and tolerability of clofazimine as salvage therapy for atypical mycobacterial infection in solid organ transplant recipients. Transpl Infect Dis 2015; 17:111–118.
Meybeck A, Tetart M, Baclet V, et al. A disseminated Mycobacterium marinum infection in a renal transplant HIV-infected patient successfully treated with a bedaquiline-containing antimycobacterial treatment: a case report. Int J Infect Dis 2021; 107:176–178.
Lee DH, Zuckerman RA. Herpes simplex virus infections in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019; 33:e13526.
Kwon DE, Lee HS, Lee KH, et al. Incidence of herpes zoster in adult solid organ transplant recipients: a meta-analysis and comprehensive review. Transpl Infect Dis 2021; 23:e13674.
Malahe SRK, van Kampen JJA, Manintveld OC, et al. Current perspectives on the management of herpesvirus infections in solid organ transplant recipients. Viruses 2023; 15:1595.
Pergam SA, Limaye AP. Varicella zoster virus in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019; 33:e13622.
http://www.cdc.gov/shingles/hcp/hc-settings.html .
Vink P, Ramon Torrell JM, Sanchez Fructuoso A, et al. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant: a phase 3, randomized clinical trial. Clin Infect Dis 2020; 70:181–190.
Antonio R, Laura G, Nicolina C, et al. Donor-derived human herpesvirus 8 infection with Kaposi sarcoma and Kaposi sarcoma inflammatory cytokine syndrome in a heart transplant recipient: a case report. Transpl Infect Dis 2021; 23:e13609.
Mularoni A, Gallo A, Riva G, et al. Successful treatment of kaposi sarcoma-associated herpesvirus inflammatory cytokine syndrome after kidney-liver transplant: correlations with the human herpesvirus 8 miRNome and specific T cell response. Am J Transplant 2017; 17:2963–2969.
Dollard SC, Annambhotla P, Wong P, et al. Donor-derived human herpesvirus 8 and development of Kaposi sarcoma among 6 recipients of organs from donors with high-risk sexual and substance use behavior. Am J Transplant 2021; 21:681–688.
Pellett Madan R, Hand J. Human herpesvirus 6, 7, and 8 in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019; 33:e13518.
Chin-Hong PV, Reid GE. Practice ASTIDCo. Human papillomavirus infection in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019; 33:e13590.
Miyaji KT, Infante V, Picone CM, et al. Human Papillomavirus (HPV) seroprevalence, cervical HPV prevalence, genotype distribution and cytological lesions in solid organ transplant recipients and immunocompetent women in Sao Paulo, Brazil. PLoS One 2022; 17:e0262724.
Papastamelos C, Linder M. Human papillomavirus anogenital screening in solid organ transplant recipients: a narrative review. Arch Gynecol Obstet 2023; 307:1277–1283.
Boey L, Curinckx A, Roelants M, et al. Immunogenicity and safety of the 9-valent human papillomavirus vaccine in solid organ transplant recipients and adults infected with human immunodeficiency virus (HIV). Clin Infect Dis 2021; 73:e661–e671.
https://www.who.int/news/item/11-05-2023-fifth-meeting-of-the-international-health-regulations-(2005)-(ihr)-emergency-committee-on-the-multicountry-outbreak-of-monkeypox-.(mpox ).
https://www.who.int/publications/m/item/multicountry-outbreak-of-mpox--external-situation-report-28---19-september-2023 .
Attieh RM, Brumble L, Elwasila SM, Wadei HM. Disseminated monkeypox infection in a kidney transplant recipient: a case report. Transplant Proc 2023; 55:667–671.
Raccagni AR, Mileto D, Candela C, et al. Monkeypox infection in a hemopoietic stem cell and heart transplant recipient. J Med Virol 2023; 95:e28304.
Heis F, Heis M, Khan M, Ashok M. Monkeypox in a renal transplant recipient: is it a hazard for immunocompromised patients? Eur J Case Rep Intern Med 2023; 10:003857.
Schmalzle SA, Hanes DS, Taylor G. Clinical course of human monkeypox infection in a renal transplant recipient living with human immunodeficiency virus. Transpl Infect Dis 2023; 25:e13975.
https://www.ema.europa.eu/en/documents/product-information/tecovirimat-siga-epar-product- information_en.pdf .
https://www.cdc.gov/poxvirus/mpox/clinicians/obtaining-tecovirimat.html .
Peghin M, Grossi PA. Donor-derived infections in solid organ transplant recipients. Curr Opin Organ Transplant 2023; 28:384–390.
Peghin M, Ruiz-Camps I. Recent concepts in fungal involvement in skin and soft tissue infections. Curr Opin Infect Dis 2022; 35:103–111.
Borman AM, Fraser M, Patterson Z, et al. Fungal infections of implantation: more than five years of cases of subcutaneous fungal infections seen at the uk mycology reference laboratory. J Fungi (Basel) 2022; 8:343.
Galezowski A, Delyon J, Le Cleach L, et al. Deep cutaneous fungal infections in solid-organ transplant recipients. J Am Acad Dermatol 2020; 83:455–462.
Gushiken AC, Saharia KK, Baddley JW. Cryptococcosis. Infect Dis Clin North Am 2021; 35:493–514.
Toivonen A, Eriksson M, Friberg N, et al. Clinical characteristics and evaluation of the incidence of cryptococcosis in Finland. Infect Dis (Lond) 2021; 53:684–690.
Penumarthi LR, La Hoz RM, Wolfe CR, et al. Cryptococcus transmission through solid organ transplantation in the United States: a report from the Ad Hoc Disease Transmission Advisory Committee. Am J Transplant 2021; 21:1911–1923.
Danion F, Coste A, Le Hyaric C, et al. What is new in pulmonary mucormycosis? J Fungi (Basel) 2023; 9:307.
Vulsteke JB, Deeren D. Cutaneous mucormycosis. Transpl Infect Dis 2019; 21:e13039.
Avkan Oguz V, Karabicak N, Irmak C, Unek T. Fusarium solani species complex infection treated with posaconazole in a liver transplantation patient; a case report. J Mycol Med 2023; 33:101382.
Park H, Bae S, Kim MJ, et al. Clinical characteristics and outcomes of invasive and noninvasive fusariosis in South Korea. Mycoses 2023; 66:211–218.
Perez-Nadales E, Alastruey-Izquierdo A, Linares-Sicilia MJ, et al. Invasive fusariosis in nonneutropenic patients, Spain, 2000–2015. Emerg Infect Dis 2021; 27:26–35.
McBride JA, Sterkel AK, Matkovic E, et al. Clinical manifestations and outcomes in immunocompetent and immunocompromised patients with blastomycosis. Clin Infect Dis 2021; 72:1594–1602.
Felipe CRA, Silva AD, Moreira Guimaraes Penido MG. Disseminated paracoccidioidomycosis in a kidney transplant recipient. Cureus 2021; 13:e19007.
Mehta TI, Kurman J, Dolan S, et al. Blastomycosis in solid organ transplant recipients—a retrospective series from southeastern Wisconsin. Transpl Infect Dis 2021; 23:e13671.
Radcliffe C, Radcliffe AJ, Azar MM, Grant M. Dematiaceous fungal infections in solid organ transplantation: systematic review and Bayesian meta-analysis. Transpl Infect Dis 2022; 24:e13819.
Lima ACC, Santos D, Hirata SH, et al. Therapeutic management of subcutaneous phaeohyphomycosis and chromoblastomycosis in kidney transplant recipients: a retrospective study of 82 cases in a single center. Int J Dermatol 2022; 61:346–351.
Abad CLR, Bhaimia E, Schuetz AN, Razonable RR. A comprehensive review of Strongyloides stercoralis infection after solid organ and hematopoietic stem cell transplantation. Clin Transplant 2022; 36:e14795.
Silva JT, Fernandez-Ruiz M, Grossi PA, et al. Reactivation of latent infections in solid organ transplant recipients from sub-Saharan Africa: what should be remembered? Transplant Rev (Orlando) 2021; 35:100632.
Gryschek RCB, Corral MA, Sitta RB, et al. Strongyloides infection screening in transplant candidates: what is the best strategy? Transpl Infect Dis 2023; 26:e14153.
Rojas OC, Montoya AM, Villanueva-Lozano H, Carrion-Alvarez D. Severe strongyloidiasis: a systematic review and meta-analysis of 339 cases. Trans R Soc Trop Med Hyg 2023; 117:682–696.
Adeyemo A, Montgomery S, Chancey RJ, et al. Investigation of donor-derived Strongyloides stercoralis infection in multiple solid organ transplant recipients-California, Michigan, Ohio, 2022. Transpl Infect Dis 2023; 25:e14059.
Stroffolini G, Tamarozzi F, Fittipaldo A, et al. Impact of preventive chemotherapy on Strongyloides stercoralis : a systematic review and meta-analysis. PLoS Negl Trop Dis 2023; 17:e0011473.
La Hoz RM, Morris MI. Infectious Diseases Community of Practice of the American Society of Transplantation Infectious Diseases. Tissue and blood protozoa including toxoplasmosis, Chagas disease, leishmaniasis, Babesia, Acanthamoeba, Balamuthia, and Naegleria in solid organ transplant recipients – guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019; 33:e13546.
Clemente WT, Mourao PHO, Lopez-Medrano F, et al. Visceral and cutaneous leishmaniasis recommendations for solid organ transplant recipients and donors. Transplantation 2018; 102: (Suppl 2): S8–S15.
تواريخ الأحداث: Date Created: 20231205 Date Completed: 20240228 Latest Revision: 20240603
رمز التحديث: 20240603
DOI: 10.1097/QCO.0000000000000998
PMID: 38050739
قاعدة البيانات: MEDLINE
الوصف
تدمد:1473-6527
DOI:10.1097/QCO.0000000000000998